Q3 results strong, Rs 42.7 Cr warrant conversion, MD re-appointed

Revenue Growth 20pctPat Growth 25pctRelated Party TransactionsResults View source PDF Explain this filing

LORDSCHLO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.9%Reaction day

₹154.08

prior close

₹155.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-6.9% vs market

Commodity Chemicals peers, median of 53sector+0.3%-6.2% vs sector

On the reaction day the stock moved 6.9 pts less than Nifty Microcap 250 and 6.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.9

10m

-4.2

15m

-4.2

30m

-5.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.9+1.0-6.9+0.3-6.2

Next day

-8.6+0.5-9.1-0.3-8.3

-10.1-0.0-10.1-0.4-9.8

-8.2-1.5-6.8-1.6-6.7

-12.4-2.2-10.2-2.7-9.7

-15.8-1.2-14.5-3.0-12.7

-18.1-2.4-15.8-3.5-14.6

15d

-19.3-8.8-10.5-7.6-11.7

-20.2-8.3-11.9-9.4-10.7

-0.1-3.5+3.5-5.9+5.8

-5.5+6.4-11.9+2.5-8.0

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lords Chloro Alkali reported Q3 FY26 revenue of about Rs 94 crore, up over 40% YoY, with PAT of about Rs 4.6 crore vs Rs 1.3 crore last year. 9M revenue rose to Rs 295 crore. Board approved conversion of 35 lakh warrants into equity shares at Rs 122 each, raising Rs 42.70 crore, mainly to promoters. Re-appointed MD Ajay Virmani for 5 years, approved ESOP scheme, and set EGM for March 18, 2026.

Likely market impact

Strong revenue and profit growth. Rs 42.7 Cr raised from promoters. MD continuity assured. Minor equity dilution from warrant conversion.